Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa
- PMID: 2127368
- DOI: 10.1111/j.1574-6968.1990.tb03528.x
Opsonic and protective activity of five human IgM monoclonal antibodies reactive with lipopolysaccharide antigen of Pseudomonas aeruginosa
Abstract
International Antigen Typing Schema (IATS) serotypes 1, 2, 5, 6, 8 and 11 comprise approximately 80% of Pseudomonas aeruginosa strains isolated from blood, wounds and respiratory specimens. Five human immunoglobulin M (IgM) monoclonal antibodies (MAbs) reactive with lipopolysaccharide O antigens of these IATS serotypes were studied in an opsonophagocytic assay. The assay employed human polymorphonuclear leukocytes, 2% guinea pig serum as the complement source and MAb. Each MAb promoted killing of inoculum of the homologous LPS serotype. The opsonic activity of each MAb was complement-dependent. In a murine model of Pseudomonas burn wound sepsis the LD50 of five strains of P. aeruginosa was increased greater than or equal to 22-fold by MAb-treatment (1.0 mg/kg). The mean effective dose of the five MAbs in mice challenged with approximately 10 LD50 of the homologous LPS serotype ranged from less than 0.01 mg/kg to 1.00 mg/kg.
Similar articles
-
Preclinical in vitro and in vivo characterization of the fully human monoclonal IgM antibody KBPA101 specific for Pseudomonas aeruginosa serotype IATS-O11.Antimicrob Agents Chemother. 2010 Jun;54(6):2338-44. doi: 10.1128/AAC.01142-09. Epub 2010 Mar 22. Antimicrob Agents Chemother. 2010. PMID: 20308370 Free PMC article.
-
Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis.Infect Immun. 2001 Apr;69(4):2223-9. doi: 10.1128/IAI.69.4.2223-2229.2001. Infect Immun. 2001. PMID: 11254577 Free PMC article.
-
Multi-valent human monoclonal antibody preparation against Pseudomonas aeruginosa derived from transgenic mice containing human immunoglobulin loci is protective against fatal pseudomonas sepsis caused by multiple serotypes.Vaccine. 2005 May 9;23(25):3264-71. doi: 10.1016/j.vaccine.2005.01.088. Vaccine. 2005. PMID: 15837231
-
Pseudomonas aeruginosa antigens as potential vaccines.FEMS Microbiol Rev. 1997 Nov;21(3):243-77. doi: 10.1111/j.1574-6976.1997.tb00353.x. FEMS Microbiol Rev. 1997. PMID: 9451816 Review.
-
Monoclonal antibodies for treatment of gram-negative infections.Rev Infect Dis. 1989 Nov-Dec;11 Suppl 7:S1564-71. doi: 10.1093/clinids/11.supplement_7.s1564. Rev Infect Dis. 1989. PMID: 2690294 Review.
Cited by
-
A bittersweet fate: detection of serotype switching in Pseudomonas aeruginosa.Microb Genom. 2023 Jan;9(1):mgen000919. doi: 10.1099/mgen.0.000919. Microb Genom. 2023. PMID: 36748704 Free PMC article.
-
The Role of Pseudomonas aeruginosa Lipopolysaccharide in Bacterial Pathogenesis and Physiology.Pathogens. 2019 Dec 19;9(1):6. doi: 10.3390/pathogens9010006. Pathogens. 2019. PMID: 31861540 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources